Follow-up of patients with endometriosis treated with danazol. 1979

J A Chalmers, and P C Shervington

Since 1975, 65 cases of endometriosis have been treated with danazol, and in an attempt to retain effective management with a minimum of side effects, three different dosage scheme providing 600 mg (Group 1) 400 mg (Group 2) or 200 mg daily (Group 3) have been used. At present 20 cases in Group 1, 16 in Group 2 and 12 in Group 3 are available for assessment and the results are here presented.

UI MeSH Term Description Entries
D008599 Menstruation Disturbances Variations of MENSTRUATION which may be indicative of disease. Hypomenorrhea,Menstruation Disorders,Menstruation, Retrograde,Polymenorrhea,Irregular Menses,Irregular Menstruation,Menstrual Irregularities,Menstrual Irregularity,Disorder, Menstruation,Disorders, Menstruation,Disturbance, Menstruation,Disturbances, Menstruation,Irregularity, Menstrual,Menses, Irregular,Menstruation Disorder,Menstruation Disturbance,Menstruation, Irregular,Retrograde Menstruation
D011245 Pregnadienes Pregnane derivatives containing two double bonds anywhere within the ring structures.
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D003613 Danazol A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders. Azol,Cyclomen,Danatrol,Danazant,Danazol-Ratiopharm,Danocrine,Danol,Danoval,Ladogal,Norciden,Panacrine,Danazol Ratiopharm
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004715 Endometriosis A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum. Endometrioma,Endometriomas,Endometrioses
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D005833 Genital Neoplasms, Female Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE). Gynecologic Neoplasms,Female Genital Neoplasms,Neoplasms, Female Genital,Neoplasms, Gynecologic,Female Genital Neoplasm,Genital Neoplasm, Female,Gynecologic Neoplasm,Neoplasm, Female Genital,Neoplasm, Gynecologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J A Chalmers, and P C Shervington
November 1979, Fertility and sterility,
J A Chalmers, and P C Shervington
March 1991, Obstetrics and gynecology,
J A Chalmers, and P C Shervington
June 1982, Fertility and sterility,
J A Chalmers, and P C Shervington
November 1989, British journal of clinical practice. Supplement,
J A Chalmers, and P C Shervington
January 2001, Nihon rinsho. Japanese journal of clinical medicine,
J A Chalmers, and P C Shervington
September 1985, Obstetrics and gynecology,
J A Chalmers, and P C Shervington
September 1987, Akusherstvo i ginekologiia,
J A Chalmers, and P C Shervington
February 1976, The Journal of the Maine Medical Association,
J A Chalmers, and P C Shervington
March 1987, Orvosi hetilap,
J A Chalmers, and P C Shervington
January 1975, American journal of obstetrics and gynecology,
Copied contents to your clipboard!